标题
Acinetobacter baumannii Resistance: A Real Challenge for Clinicians
作者
关键词
-
出版物
Antibiotics-Basel
Volume 9, Issue 4, Pages 205
出版商
MDPI AG
发表日期
2020-04-24
DOI
10.3390/antibiotics9040205
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- 2-Hydroxylation of Acinetobacter baumannii Lipid A Contributes to Virulence
- (2019) Toby L. Bartholomew et al. INFECTION AND IMMUNITY
- Phage Therapy as a Promising New Treatment for Lung Infection Caused by Carbapenem-Resistant Acinetobacter baumannii in Mice
- (2018) Yunfen Hua et al. Frontiers in Microbiology
- Molecular characterization of plasmid-encoded blaTEM, blaSHV and blaCTX-M among extended spectrum β-lactamases [ESBLs] producing Acinetobacter baumannii
- (2018) ASG Smiline et al. BRITISH JOURNAL OF BIOMEDICAL SCIENCE
- Prevalence and Mechanisms of Carbapenem Resistance Among Acinetobacter baumannii Clinical Isolates in Egypt
- (2018) Abdalbagi Basheer Benmahmod et al. Microbial Drug Resistance
- TimeTree: A Resource for Timelines, Timetrees, and Divergence Times
- (2017) Sudhir Kumar et al. MOLECULAR BIOLOGY AND EVOLUTION
- Uncovering the mechanisms of Acinetobacter baumannii virulence
- (2017) Christian M. Harding et al. NATURE REVIEWS MICROBIOLOGY
- Biology of Acinetobacter baumannii: Pathogenesis, Antibiotic Resistance Mechanisms, and Prospective Treatment Options
- (2017) Chang-Ro Lee et al. Frontiers in Cellular and Infection Microbiology
- Global Assessment of the Activity of Tigecycline against Multidrug-Resistant Gram-Negative Pathogens between 2004 and 2014 as Part of the Tigecycline Evaluation and Surveillance Trial
- (2017) Anna Giammanco et al. mSphere
- Clinical Antibiotic-resistant Acinetobacter baumannii Strains with Higher Susceptibility to Environmental Phages than Antibiotic-sensitive Strains
- (2017) Li-Kuang Chen et al. Scientific Reports
- In VitroBactericidal Activity of Trimethoprim-Sulfamethoxazole Alone and in Combination with Colistin against Carbapenem-Resistant Acinetobacter baumannii Clinical Isolates
- (2016) Martha Nepka et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroActivity of Fusidic Acid-Containing Combinations against Carbapenem-Resistant Acinetobacter baumannii Clinical Strains
- (2016) Sarah L. Bowler et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroSynergistic Activity of Antimicrobial Agents in Combination against Clinical Isolates of Colistin-Resistant Acinetobacter baumannii
- (2016) Seongman Bae et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VivoApplication of Bacteriophage as a Potential Therapeutic Agent To Control OXA-66-Like Carbapenemase-Producing Acinetobacter baumannii Strains Belonging to Sequence Type 357
- (2016) Jongsoo Jeon et al. APPLIED AND ENVIRONMENTAL MICROBIOLOGY
- Clinical and Pathophysiological Overview of Acinetobacter Infections: a Century of Challenges
- (2016) Darren Wong et al. CLINICAL MICROBIOLOGY REVIEWS
- Colistin enhances therapeutic efficacy of daptomycin or teicoplanin in a murine model of multiresistant Acinetobacter baumannii sepsis
- (2016) Oscar Cirioni et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Synergistic killing by meropenem and colistin combination of carbapenem-resistant Acinetobacter baumannii isolates from Chinese patients in an in vitro pharmacokinetic/pharmacodynamic model
- (2016) Xiaofen Liu et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Regional differences and trends in antimicrobial susceptibility of Acinetobacter baumannii
- (2016) Sibylle H. Lob et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Polymyxin B in combination with doripenem against heteroresistant Acinetobacter baumannii : pharmacodynamics of new dosing strategies
- (2016) Gauri G. Rao et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- High rate of colistin dependence inAcinetobacter baumannii
- (2016) Yoon-Kyoung Hong et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Activity of Colistin in Combination with Meropenem, Tigecycline, Fosfomycin, Fusidic Acid, Rifampin or Sulbactam against Extensively Drug-Resistant Acinetobacter baumannii in a Murine Thigh-Infection Model
- (2016) Bing Fan et al. PLoS One
- Colistin-Resistant Acinetobacter baumannii: Beyond Carbapenem Resistance
- (2015) Zubair A. Qureshi et al. CLINICAL INFECTIOUS DISEASES
- Structural Basis for Carbapenem-Hydrolyzing Mechanisms of Carbapenemases Conferring Antibiotic Resistance
- (2015) Jeong Jeon et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Risk factors for nephrotoxicity onset associated with polymyxin B therapy
- (2015) Y. Dubrovskaya et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Acinetobacter baumannii: Evolution of Antimicrobial Resistance—Treatment Options
- (2015) Gerald Murray et al. SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE
- Reinforcing Lipid A Acylation on the Cell Surface of Acinetobacter baumannii Promotes Cationic Antimicrobial Peptide Resistance and Desiccation Survival
- (2015) Joseph M. Boll et al. mBio
- Antibacterial Mechanisms of Polymyxin and Bacterial Resistance
- (2015) Zhiliang Yu et al. Biomed Research International
- Clinical Outcomes of Hospital-Acquired Infection with Acinetobacter nosocomialis and Acinetobacter pittii
- (2014) Sarunyou Chusri et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antibacterial properties of Acinetobacter baumanniiphage Abp1 endolysin (PlyAB1)
- (2014) Guangtao Huang et al. BMC INFECTIOUS DISEASES
- Treatment Options for Carbapenem-Resistant and Extensively Drug-Resistant Acinetobacter baumannii Infections
- (2014) J. Alexander Viehman et al. DRUGS
- Comparison of colistin–carbapenem, colistin–sulbactam, and colistin plus other antibacterial agents for the treatment of extremely drug-resistant Acinetobacter baumannii bloodstream infections
- (2014) A. Batirel et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- The Genomic Diversification of the Whole Acinetobacter Genus: Origins, Mechanisms, and Consequences
- (2014) Marie Touchon et al. Genome Biology and Evolution
- Multistate Point-Prevalence Survey of Health Care–Associated Infections
- (2014) Shelley S. Magill et al. NEW ENGLAND JOURNAL OF MEDICINE
- Engineered Endolysin-Based "Artilysins" To Combat Multidrug-Resistant Gram-Negative Pathogens
- (2014) Y. Briers et al. mBio
- Antimicrobial resistance inAcinetobacter baumannii: From bench to bedside
- (2014) Ming-Feng Lin World Journal of Clinical Cases
- The Biology of the PmrA/PmrB Two-Component System: The Major Regulator of Lipopolysaccharide Modifications
- (2013) H. Deborah Chen et al. Annual Review of Microbiology
- In VitroPharmacodynamics of Polymyxin B and Tigecycline Alone and in Combination against Carbapenem-Resistant Acinetobacter baumannii
- (2013) Mao Hagihara et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Contribution of Efflux Pumps, Porins, and β-Lactamases to Multidrug Resistance in Clinical Isolates of Acinetobacter baumannii
- (2013) C. Rumbo et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- OXA-235, a Novel Class D β-Lactamase Involved in Resistance to Carbapenems in Acinetobacter baumannii
- (2013) Paul G. Higgins et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Virulence-related traits of epidemic Acinetobacter baumannii strains belonging to the international clonal lineages I-III and to the emerging genotypes ST25 and ST78
- (2013) Maria Giannouli et al. BMC INFECTIOUS DISEASES
- Population Pharmacokinetics of Intravenous Polymyxin B in Critically Ill Patients: Implications for Selection of Dosage Regimens
- (2013) Ana M. Sandri et al. CLINICAL INFECTIOUS DISEASES
- Seven Ways to Preserve the Miracle of Antibiotics
- (2013) J. G. Bartlett et al. CLINICAL INFECTIOUS DISEASES
- Carbapenem resistance and mortality in patients with Acinetobacter baumannii infection: systematic review and meta-analysis
- (2013) E.V. Lemos et al. CLINICAL MICROBIOLOGY AND INFECTION
- Pharmacology of polymyxins: new insights into an ‘old’ class of antibiotics
- (2013) Tony Velkov et al. Future Microbiology
- TEM-1 -lactamase as a source of resistance to sulbactam in clinical strains of Acinetobacter baumannii
- (2013) L. Krizova et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Real-Time Sequencing To Decipher the Molecular Mechanism of Resistance of a Clinical Pan-Drug-Resistant Acinetobacter baumannii Isolate from Marseille, France
- (2012) Jean-Marc Rolain et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Rapid Killing of Acinetobacter baumannii by Polymyxins Is Mediated by a Hydroxyl Radical Death Pathway
- (2012) Timothy R. Sampson et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Colistin vs. the combination of colistin and rifampicin for the treatment of carbapenem-resistant Acinetobacter baumannii ventilator-associated pneumonia
- (2012) H. AYDEMIR et al. EPIDEMIOLOGY AND INFECTION
- Colistin: an update on the antibiotic of the 21st century
- (2012) Silpak Biswas et al. Expert Review of Anti-Infective Therapy
- Bacteriophage endolysins as novel antimicrobials
- (2012) Mathias Schmelcher et al. Future Microbiology
- Colistin resistance of Acinetobacter baumannii: clinical reports, mechanisms and antimicrobial strategies
- (2012) Y. Cai et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Risk Factors for Mortality in Patients with Carbapenem-Resistant Acinetobacter baumannii Bacteremia: Impact of Appropriate Antimicrobial Therapy
- (2012) Youn Jeong Kim et al. JOURNAL OF KOREAN MEDICAL SCIENCE
- Role of ISAba1 and ISAba125 in governing the expression of blaADC in clinically relevant Acinetobacter baumannii strains resistant to cephalosporins
- (2012) B. S. Lopes et al. JOURNAL OF MEDICAL MICROBIOLOGY
- Genetic Mechanisms of Antimicrobial Resistance of Acinetobacter Baumannii
- (2011) John S Esterly et al. ANNALS OF PHARMACOTHERAPY
- Extended-Spectrum AmpC Cephalosporinase in Acinetobacter baumannii: ADC-56 Confers Resistance to Cefepime
- (2011) Guo-Bao Tian et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- ThepmrCABOperon Mediates Polymyxin Resistance inAcinetobacter baumanniiATCC 17978 and Clinical Isolates through Phosphoethanolamine Modification of Lipid A
- (2011) Luis A. Arroyo et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Phosphoethanolamine Modification of Lipid A in Colistin-Resistant Variants of Acinetobacter baumannii Mediated by the pmrAB Two-Component Regulatory System
- (2011) Alejandro Beceiro et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Activities of colistin- and minocycline-based combinations against extensive drug resistant Acinetobacter baumannii isolates from intensive care unit patients
- (2011) Wang Liang et al. BMC INFECTIOUS DISEASES
- Comparative in vitro antimicrobial susceptibilities and synergistic activities of antimicrobial combinations against carbapenem-resistant Acinetobacter species: Acinetobacter baumannii versus Acinetobacter genospecies 3 and 13TU
- (2011) Wang-Huei Sheng et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Molecular epidemiology and mechanisms of rifampicin resistance in Acinetobacter baumannii isolates from Italy
- (2011) Maria Giannouli et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- In vitro activity of teicoplanin combined with colistin versus multidrug-resistant strains of Acinetobacter baumannii
- (2011) D. W. Wareham et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Emergence of NDM-1-producing Acinetobacter baumannii in China
- (2011) Y. Chen et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- In vitro time-kill studies of antimicrobial agents against blood isolates of imipenem-resistant Acinetobacter baumannii, including colistin- or tigecycline-resistant isolates
- (2011) Kyong Ran Peck et al. JOURNAL OF MEDICAL MICROBIOLOGY
- Deciphering the Multifactorial Nature of Acinetobacter baumannii Pathogenicity
- (2011) Luísa C. S. Antunes et al. PLoS One
- Efficacy of Rifampin and Its Combinations with Imipenem, Sulbactam, and Colistin in Experimental Models of Infection Caused by Imipenem-Resistant Acinetobacter baumannii
- (2010) M. E. Pachon-Ibanez et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Overexpression of Resistance-Nodulation-Cell Division Pump AdeFGH Confers Multidrug Resistance in Acinetobacter baumannii
- (2010) S. Coyne et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Efflux-Mediated Antibiotic Resistance inAcinetobacterspp.
- (2010) Sébastien Coyne et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Colistin Resistance in Acinetobacter baumannii Is Mediated by Complete Loss of Lipopolysaccharide Production
- (2010) J. H. Moffatt et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Postantibiotic Effects of Tigecycline, Colistin Sulfate, and Levofloxacin Alone or Tigecycline-Colistin Sulfate and Tigecycline-Levofloxacin Combinations against Acinetobacter baumannii
- (2010) Berna Özbek et al. CHEMOTHERAPY
- The 10 × ‘20 Initiative: Pursuing a Global Commitment to Develop 10 New Antibacterial Drugs by 2020
- (2010) CLINICAL INFECTIOUS DISEASES
- Influence of Genospecies of Acinetobacter baumannii Complex on Clinical Outcomes of Patients with Acinetobacter Bacteremia
- (2010) Y.-C. Chuang et al. CLINICAL INFECTIOUS DISEASES
- The K1 Capsular Polysaccharide of Acinetobacter baumannii Strain 307-0294 Is a Major Virulence Factor
- (2010) T. A. Russo et al. INFECTION AND IMMUNITY
- Inactivation of Phospholipase D Diminishes Acinetobacter baumannii Pathogenesis
- (2010) A. C. Jacobs et al. INFECTION AND IMMUNITY
- Identification and Characterization of a Glycosyltransferase Involved in Acinetobacter baumannii Lipopolysaccharide Core Biosynthesis
- (2010) N. R. Luke et al. INFECTION AND IMMUNITY
- Clinical Outcomes of Carbapenem-Resistant Acinetobacter baumannii Bloodstream Infections: Study of a 2-State Monoclonal Outbreak
- (2010) L. Silvia Munoz-Price et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Multidrug-resistant Acinetobacter baumannii: mechanisms of virulence and resistance
- (2010) Nicola C. Gordon et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- A multicenter study of risk factors and outcome of hospitalized patients with infections due to carbapenem-resistant Acinetobacter baumannii
- (2010) Wang-Huei Sheng et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Antimicrobial activity of a novel aminoglycoside, ACHN-490, against Acinetobacter baumannii and Pseudomonas aeruginosa from New York City
- (2010) D. Landman et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- AdeABC-mediated efflux and tigecycline MICs for epidemic clones of Acinetobacter baumannii
- (2010) M. Hornsey et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Aminoglycoside Resistance and Susceptibility Testing Errors in Acinetobacter baumannii-calcoaceticus Complex
- (2010) K. S. Akers et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Dissection of Host Cell Signal Transduction during Acinetobacter baumannii – Triggered Inflammatory Response
- (2010) Catalina March et al. PLoS One
- Molecular Mechanisms of Ethanol-Induced Pathogenesis Revealed by RNA-Sequencing
- (2010) Laura Camarena et al. PLoS Pathogens
- Overexpression of the Naturally Occurring blaOXA-51 Gene in Acinetobacter baumannii Mediated by Novel Insertion Sequence ISAba9
- (2009) S. Figueiredo et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Tetracycline Susceptibility Testing and Resistance Genes in Isolates of Acinetobacter baumannii-Acinetobacter calcoaceticus Complex from a U.S. Military Hospital
- (2009) K. S. Akers et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro Activity of Colistin (Polymyxin E) against 3,480 Isolates of Gram-Negative Bacilli Obtained from Patients in Canadian Hospitals in the CANWARD Study, 2007-2008
- (2009) A. Walkty et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Genetic basis of resistance to aminoglycosides in Acinetobacter spp. and spread of armA in Acinetobacter baumannii sequence group 1 in Korean hospitals
- (2009) Yoo Jin Cho et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Serum resistance ofAcinetobacter baumanniithrough the binding of factor H to outer membrane proteins
- (2009) Sang Woo Kim et al. FEMS MICROBIOLOGY LETTERS
- Proteome analysis of outer membrane vesicles from a clinicalAcinetobacter baumanniiisolate
- (2009) Sang-Oh Kwon et al. FEMS MICROBIOLOGY LETTERS
- The Acinetobacter baumannii 19606 OmpA Protein Plays a Role in Biofilm Formation on Abiotic Surfaces and in the Interaction of This Pathogen with Eukaryotic Cells
- (2009) J. A. Gaddy et al. INFECTION AND IMMUNITY
- Tigecycline use in two cases with multidrug-resistant Acinetobacter baumannii meningitis
- (2009) E. Ediz Tutuncu et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- The pgaABCD Locus of Acinetobacter baumannii Encodes the Production of Poly- -1-6-N-Acetylglucosamine, Which Is Critical for Biofilm Formation
- (2009) A. H. K. Choi et al. JOURNAL OF BACTERIOLOGY
- Acinetobacter: an old friend, but a new enemy
- (2009) K.J. Towner JOURNAL OF HOSPITAL INFECTION
- In vitro activity of tigecycline in combination with various antimicrobials against multidrug resistant Acinetobacter baumannii
- (2009) Luigi Principe et al. Annals of Clinical Microbiology and Antimicrobials
- Genetic Basis of Multidrug Resistance in Acinetobacter baumannii Clinical Isolates at a Tertiary Medical Center in Pennsylvania
- (2008) J. M. Adams-Haduch et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Acinetobacter baumannii invades epithelial cells and outer membrane protein A mediates interactions with epithelial cells
- (2008) Chul Hee Choi et al. BMC MICROBIOLOGY
- Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
- (2008) Helen W. Boucher et al. CLINICAL INFECTIOUS DISEASES
- Acinetobacter baumannii: Emergence of a Successful Pathogen
- (2008) A. Y. Peleg et al. CLINICAL MICROBIOLOGY REVIEWS
- Global gene expression patterns and induction of innate immune response in human laryngeal epithelial cells in response toAcinetobacter baumanniiouter membrane protein A
- (2008) Soon Ae Kim et al. FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY
- Nuclear translocation and DNAse I-like enzymatic activity ofAcinetobacter baumanniiouter membrane protein A
- (2008) Chul Hee Choi et al. FEMS MICROBIOLOGY LETTERS
- Comparative Analysis of Acinetobacters: Three Genomes for Three Lifestyles
- (2008) David Vallenet et al. PLoS One
- Capacity of multidrug-resistant clinical isolates of Acinetobacter baumannii to form biofilm and adhere to epithelial cell surfaces
- (2007) H.-W. Lee et al. CLINICAL MICROBIOLOGY AND INFECTION
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation